Baseline Characteristics in Patients with Atopic Dermatitis from the North American Prospective Observational Study of Lebrikizumab (ADjoy). J of Skin [Internet]. 2026 Mar. 10 [cited 2026 Apr. 29];10(2):s734. Available from: https://skin.dermsquared.com/skin/article/view/4054